GLP-1 telehealth runs on two visit architectures. Asynchronous: you complete an intake, a licensed clinician reviews it on their own schedule, and you interact through portal messages. Synchronous: a scheduled live video (or phone) appointment with a clinician in real time. Neither is inherently better medicine — but they fit different patients, and in some states the choice isn't yours.
Key Takeaways
- Async is faster (often prescribed within 24–72 hours) and usually cheaper; video offers real-time dialogue and better complexity handling.
- Several states restrict questionnaire-only prescribing, so platforms route you to video based on your address automatically.
- Complex patients — multiple medications, diabetes, GI history — get objectively better care from a live conversation.
- The strongest programs are hybrid: async speed for routine steps, escalation to live clinicians when your situation needs it.
How Async Actually Works
Your intake becomes a chart; a clinician licensed in your state reviews it, may message follow-up questions, and prescribes if appropriate. Total elapsed time is commonly 24–72 hours from intake to pharmacy. The quality question is entirely about what happens in that review — a thoughtful async review with real follow-up questions is legitimate medicine; a rubber stamp is not, and from the outside they look identical until you're a customer.
How Video Changes the Picture
A live visit lets the clinician probe answers in real time — the follow-up question you didn't know your pancreatitis history warranted, the interaction check on the medication you forgot to list. It's harder to rubber-stamp a face. Costs run higher and scheduling adds days, but for anyone whose history has moving parts, the dialogue is worth it.
The State-Law Layer
Telehealth prescribing rules are state law, and several states require some form of real-time interaction to establish a valid patient relationship. Practically: the same platform may be async in one state and video-required in the next, and your address at intake determines your route. If a platform advertises "no video ever, all 50 states," treat the claim skeptically — it's describing its marketing, not the regulatory map.
Which Model for Which Patient
| Your situation | Better fit | Why |
|---|---|---|
| Straightforward history, no daily meds | Async | Speed and price; little for a live visit to add |
| Type 2 diabetes, insulin, or sulfonylureas | Video | Real-time dose-adjustment planning matters |
| Multiple medications or GI history | Video | Interaction and contraindication dialogue |
| Rebuilding after a bad prior provider | Video first, async after | Establish trust, then use async for maintenance |
| Night-shift or unpredictable schedule | Async | No scheduling friction at all |
Programs Across the Spectrum
Compare its advertised GLP-1 offerings. Confirm formulation, legal eligibility, pharmacy sourcing and complete current pricing.
Explore BiltRx ↗Eligibility and prices must be verified directly. Compounded GLP-1 products are not FDA-approved.Explore HealthRX’s compounded semaglutide listing. Compounded medications are not FDA-approved; verify the current legal pathway, pharmacy and total price.
Explore HealthRX — semaglutide ↗Eligibility and prices must be verified directly. Compounded GLP-1 products are not FDA-approved.Gala
Injectable — $179/mo flat, every dose
Flat pricing at every dose — one of the simplest billing models in GLP-1 telehealth.
Compounded medications are not FDA-approved.
Visit Gala Paid linkThe honest bottom line: async is a triumph of convenience that's exactly as good as the clinician reviewing your file. If your file is simple, take the speed. If it isn't, buy the conversation.
Affiliate disclosure: Links marked "Paid link" are affiliate links. We may earn a commission if you sign up through them, at no extra cost to you. This supports our independent research.
Compounded medication notice: Compounded medications are not FDA-approved. The FDA does not verify the safety, effectiveness, or quality of compounded drugs before they are marketed. Brand-name alternatives (Wegovy, Ozempic, Zepbound, Rybelsus) are FDA-approved.
Medical disclaimer: This article is for informational purposes only and is not medical advice. GLP-1 medications are prescription drugs. Always consult a licensed healthcare provider about diagnosis, treatment, dosing, and whether these medications are appropriate for you.